INGN

Inogen Inc

INGN, USA

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

https://www.inogen.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
INGN
stock
INGN

Aug Momentum: Can INGN stock hit analyst price targets - Quarterly Portfolio Report & Real-Time Stock Price Movement Reports moha.gov.vn

Read more →
INGN
stock
INGN

Aug Gainers: Why INGN stock remains resilient - 2025 Technical Patterns & Smart Swing Trading Alerts moha.gov.vn

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$13

Analyst Picks

Strong Buy

1

Buy

1

Hold

0

Sell

1

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.92

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-2.68 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-1.72 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

0.07 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

High

0.56

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 75.16% of the total shares of Inogen Inc

1.

BlackRock Inc

(6.3567%)

since

2025/06/30

2.

Vanguard Group Inc

(6.1161%)

since

2025/06/30

3.

Kent Lake PR LLC

(3.9248%)

since

2025/06/30

4.

Camber Capital Management LLC

(3.6057%)

since

2025/06/30

5.

Ameriprise Financial Inc

(3.2585%)

since

2025/06/30

6.

Dimensional Fund Advisors, Inc.

(3.0776%)

since

2025/06/30

7.

Renaissance Technologies Corp

(2.6853%)

since

2025/06/30

8.

Vanguard Total Stock Mkt Idx Inv

(2.6544%)

since

2025/07/31

9.

Morgan Stanley - Brokerage Accounts

(2.5093%)

since

2025/06/30

10.

Armistice Capital, LLC

(2.4556%)

since

2025/06/30

11.

Prudential Financial Inc

(2.3934%)

since

2025/06/30

12.

Geode Capital Management, LLC

(2.2754%)

since

2025/06/30

13.

Dafna Capital Management LLC

(2.2397%)

since

2025/06/30

14.

iShares Russell 2000 ETF

(2.0951%)

since

2025/08/31

15.

Columbia Small Cap Value Discv A

(2.0865%)

since

2025/07/31

16.

Columbia Small Cap Value Discovery Fund

(2.0292%)

since

2025/06/30

17.

Royce & Associates, LP

(1.9294%)

since

2025/06/30

18.

State Street Corp

(1.8981%)

since

2025/06/30

19.

Divisadero Street Capital Management, LP

(1.6841%)

since

2025/06/30

20.

AQR Capital Management LLC

(1.6563%)

since

2025/06/30

21.

Federated Hermes Inc

(1.5655%)

since

2025/06/30

22.

JPMorgan Chase & Co

(1.4672%)

since

2025/06/30

23.

Foundry Partners Micro Cap Value

(1.3823%)

since

2025/07/31

24.

Federated Hermes MDT SCC Institutional

(1.3734%)

since

2025/06/30

25.

Federated Hermes MDT Small Cap Core IS

(1.3734%)

since

2025/06/30

26.

Royce Micro Cap Trust

(1.1509%)

since

2025/06/30

27.

Vanguard Institutional Extnd Mkt Idx Tr

(1.1257%)

since

2025/07/31

28.

Jacobs Levy Equity Management, Inc.

(1.074%)

since

2025/06/30

29.

Connor Clark & Lunn Inv Mgmt Ltd

(1.0184%)

since

2025/06/30

30.

Fidelity Small Cap Index

(0.8826%)

since

2025/06/30

31.

iShares Russell 2000 Value ETF

(0.7669%)

since

2025/08/31

32.

CREF Stock R3

(0.7644%)

since

2025/07/31

33.

DFA US Targeted Value I

(0.7492%)

since

2025/07/31

34.

Dimensional US Targeted Value ETF

(0.59%)

since

2025/08/29

35.

Columbia VP Small Cap Value 1

(0.5419%)

since

2025/07/31

36.

Royce Micro-Cap Invmt

(0.5393%)

since

2025/06/30

37.

Fidelity Extended Market Index

(0.5275%)

since

2025/07/31

38.

JPMorgan US Small Company L

(0.4899%)

since

2025/07/31

39.

Vanguard Strategic Small-Cap Equity Inv

(0.4213%)

since

2025/06/30

40.

Vanguard Russell 2000 ETF

(0.4204%)

since

2025/07/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.3424

Latest Release

Date

2025-09-30

EPS Actual

-0.2

EPS Estimate

-0.21

EPS Difference

0.01

Surprise Percent

4.7619%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(7.5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Some Competitive Advantage(5.3)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(2.5)
Momentum
No Momentum(2.5)
Net Net
Possible Net-Net(5)
Quality
Moderate Quality(4)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.